These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Maeder MT, Rickenbacher P, Rickli H, Abbühl H, Gutmann M, Erne P, Vuilliomenet A, Peter M, Pfisterer M, Brunner-La Rocca HP, TIME-CHF Investigators. Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728 [Abstract] [Full Text] [Related]
32. Correlates of Plasma NT-proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial. Chiu L, Agrawal V, Armstrong D, Brittain E, Collins S, Hemnes AR, Hill JA, Lindenfeld J, Shah SJ, Stevenson LW, Wang TJ, Gupta DK. J Am Heart Assoc; 2024 Apr 02; 13(7):e031796. PubMed ID: 38533961 [Abstract] [Full Text] [Related]
33. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects]. Wu YR, Chen SB, Huang MR, Zhang YQ, Sun K, Chen S. Zhonghua Er Ke Za Zhi; 2005 Mar 02; 43(3):161-4. PubMed ID: 15833183 [Abstract] [Full Text] [Related]
35. Study of the Role of Plasma NT-proBNP in the Diagnosis of Heart Failure. Athavale B, Pathak J. J Assoc Physicians India; 2022 Jul 02; 70(7):11-12. PubMed ID: 35833396 [Abstract] [Full Text] [Related]
36. Relation of N-Terminal Pro-B-Type Natriuretic Peptide and Left Ventricular Diastolic Function to Exercise Tolerance in Patients With Significant Valvular Heart Disease and Normal Left Ventricular Systolic Function. Hwang JW, Park SJ, Cho EJ, Kim EK, Lee GY, Chang SA, Choi JO, Lee SC, Park SW. Am J Cardiol; 2017 Jun 01; 119(11):1846-1853. PubMed ID: 28391990 [Abstract] [Full Text] [Related]
37. The impact of the glucagon-like peptide-1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes. Nielsen R, Jorsal A, Tougaard RS, Rasmussen JJ, Schou M, Videbaek L, Gustafsson I, Faber J, Flyvbjerg A, Wiggers H, Tarnow L, Kistorp C. Diabetes Obes Metab; 2020 Nov 01; 22(11):2141-2150. PubMed ID: 32627271 [Abstract] [Full Text] [Related]
38. Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP). Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Clin Chem Lab Med; 2004 Feb 01; 42(2):159-63. PubMed ID: 15061354 [Abstract] [Full Text] [Related]
39. Longitudinal evaluation of ventricular ejection fraction and NT-proBNP across heart failure subgroups. Martinsson A, Oest P, Wiborg MB, Reitan Ö, Smith JG. Scand Cardiovasc J; 2018 Aug 01; 52(4):205-210. PubMed ID: 29656687 [Abstract] [Full Text] [Related]
40. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients. Racek J, Králová H, Trefil L, Rajdl D, Eiselt J. Nephron Clin Pract; 2006 Aug 01; 103(4):c162-72. PubMed ID: 16645318 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]